Articles with "patients poems" as a keyword



Photo by aaronburden from unsplash

Validation of a prognostic score for patients with POEMS syndrome: a mayo clinic cohort

Sign Up to like & get
recommendations!
Published in 2017 at "Leukemia"

DOI: 10.1038/leu.2017.68

Abstract: We read with interest the manuscript by Wang et al. describing and validating a prognostic score for overall survival (OS) for patients with POEMS syndrome. The authors used four easily determined parameters to stratify patients… read more here.

Keywords: risk; prognostic score; study; poems syndrome ... See more keywords
Photo from wikipedia

Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndrome

Sign Up to like & get
recommendations!
Published in 2020 at "British Journal of Haematology"

DOI: 10.1111/bjh.16522

Abstract: We sought to dissect the tumour microenvironment in a small cohort (N = 10) of patients with POEMS at diagnosis and after therapy using mass cytometry. We included 10 MGUS patients as controls. We identified… read more here.

Keywords: mass cytometry; double positive; cell subsets; patients poems ... See more keywords
Photo from wikipedia

Characteristics of Serum Lipidome in Patients with POEMS Syndrome

Sign Up to like & get
recommendations!
Published in 2019 at "Blood"

DOI: 10.1182/blood-2019-122239

Abstract: OBJECTIVE: POEMS syndrome is a rare plasma cell dyscrasia. Most patients had shrinking buccal pad fat and weight loss at disease onset, indicating abnormal lipid metabolism. Manifestations of POEMS syndrome, such as the elevated serum… read more here.

Keywords: serum lipidome; figure; treatment; poems syndrome ... See more keywords
Photo by sharonmccutcheon from unsplash

Ixazomib, lenalidomide, and dexamethasone for patients with POEMS syndrome.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.15_suppl.8019

Abstract: 8019 Background: POEMS syndrome is a rare paraneoplastic syndrome caused by an underlying plasma cell disorder. Most of the information regarding treatment has been gleaned from retrospective data. The combination of a proteasome inhibitor, an… read more here.

Keywords: response; ixazomib lenalidomide; patients poems; lenalidomide dexamethasone ... See more keywords